Get startedLog in
    Picture of Consun Pharmaceutical logo

    1681 — Consun Pharmaceutical Income Statement

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareAdventurousMid CapSuper Stock
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Consun Pharmaceutical, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSPRESS
    Standards:
    HKAS
    HKAS
    HKAS
    HKAS    		—
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue1,7532,0452,3402,5902,967
    Cost of Revenue
    Gross Profit1,3221,5271,7631,9222,242
    Selling / General / Administrative Expenses
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses1,1481,3361,5821,7051,922
    Operating Profit6057097578851,045
    Total Net Non Operating Interest Income / Expense
    Net Income Before Taxes5846967468641,020
    Provision for Income Taxes
    Net Income After Taxes482587684787917
    Minority Interest
    Net Income Before Extraordinary Items
    Net Income499590683785910
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Dilution Adjustment
    Diluted Net Income499590683785921
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS0.6110.7350.8640.9831.11
    Dividends per Share
    Special Dividends per Share